biosector about to be re-rated?, page-5

amg an abdm,
Great posts,
as for sleeping investors, it seems they wake up to the fact that the recent speculation surrounding other biotechs had to eventually spill over to our company.

To see the wall of 2.4 cents go is something we all enjoy, no doubt here.

If looking at last year's events one can observe the time period end of Jan to mid of Feb is a very active time for updates within larger pharma and fast moving consumer goods companies.
The row of updates we saw last year at this period is about to be repeated, in my opinion.
Large companies usually gear up in the new year after the calm period over the holidays.
Combined with the dymanic larger forces seeing smart money entering the biotech sector on a broad scale, this is going to be a very interesting month ahead.